These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 18956999)

  • 21. A Novel Correction Equation Avoids High-Magnitude Errors in Interpreting Therapeutic Drug Monitoring of Phenytoin Among Critically Ill Patients.
    Barra ME; Phillips KM; Chung DY; Rosenthal ES
    Ther Drug Monit; 2020 Aug; 42(4):617-625. PubMed ID: 32049893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serum phenytoin monitoring in an acute care setting.
    Levine M; McCollom R; Chang T; Orr J
    Ther Drug Monit; 1988; 10(1):50-7. PubMed ID: 3376181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiepileptic TDM pattern at a tertiary care hospital in India.
    Jose VM; Medhi B; Pandhi P
    Nepal Med Coll J; 2006 Jun; 8(2):107-10. PubMed ID: 17017400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic principles of cardiovascular drug administration to the critically ill.
    Campbell S
    Crit Care Clin; 1985 Nov; 1(3):471-90. PubMed ID: 3916790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic monitoring of antiepileptic drugs: a comparison between a Czech and a Swedish University Hospital.
    Koristkova B; Bergman U; Grundmann M; Brozmanova H; Sjöqvist F
    Ther Drug Monit; 2006 Oct; 28(5):594-8. PubMed ID: 17038871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: phenytoin use and efficacy in the ED.
    Gallop K
    Emerg Med Australas; 2010 Apr; 22(2):108-18. PubMed ID: 20534046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptic drugs: pharmacokinetic and clinical aspects.
    Johannessen SI
    Ther Drug Monit; 1981; 3(1):17-37. PubMed ID: 7015579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of phenytoin drug concentration for evaluation of clinical response, uncontrolled seizures and toxicity.
    Shaikh AS; Li Y; Cao L; Guo R
    Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1697-1700. PubMed ID: 30203765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of phenytoin in critically ill trauma patients.
    Boucher BA; Rodman JH; Fabian TC; Cupit GC; Ludden TM; West ME; Ray MW
    Clin Pharm; 1987 Nov; 6(11):881-7. PubMed ID: 3677565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation.
    Kane SP; Bress AP; Tesoro EP
    Ann Pharmacother; 2013 May; 47(5):628-36. PubMed ID: 23606554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
    Tobler A; Hösli R; Mühlebach S; Huber A
    Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
    Dasgupta A; McLemore JL
    Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of phenytoin in critically ill children.
    Hennig S; Norris R; Tu Q; van Breda K; Riney K; Foster K; Lister B; Charles B
    J Clin Pharmacol; 2015 Mar; 55(3):355-64. PubMed ID: 25331445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical value of free phenytoin levels.
    Theodore WH; Yu L; Price B; Yonekawa W; Porter RJ; Kapetanovic I; Moore H; Kupferberg H
    Ann Neurol; 1985 Jul; 18(1):90-3. PubMed ID: 4037755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurological manifestations in critically ill patients].
    López-Rodríguez L; Hidalgo-Alquicira FG; Mimenza-Alvarado AJ
    Rev Neurol; 2006 Aug 1-15; 43(3):155-67. PubMed ID: 16871481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury.
    Stowe CD; Lee KR; Storgion SA; Phelps SJ
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1452-61. PubMed ID: 11185666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.